Concepts (179)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Observational Studies as Topic | 4 | 2021 | 1887 | 1.37 | Why? |
| Models, Genetic | 4 | 2019 | 434 | 1.34 | Why? |
| Phylogeny | 15 | 2021 | 13341 | 0.94 | Why? |
| Bayes Theorem | 10 | 2021 | 3237 | 0.93 | Why? |
| Software | 6 | 2021 | 2501 | 0.87 | Why? |
| Publication Bias | 1 | 2021 | 241 | 0.80 | Why? |
| Classification | 1 | 2018 | 55 | 0.72 | Why? |
| Calibration | 1 | 2018 | 307 | 0.66 | Why? |
| Bias | 3 | 2019 | 1109 | 0.62 | Why? |
| Monte Carlo Method | 5 | 2020 | 577 | 0.51 | Why? |
| Markov Chains | 4 | 2019 | 502 | 0.49 | Why? |
| Health Services Research | 1 | 2018 | 756 | 0.46 | Why? |
| Models, Immunological | 1 | 2017 | 727 | 0.44 | Why? |
| Evolution, Molecular | 6 | 2020 | 3691 | 0.44 | Why? |
| Propensity Score | 1 | 2018 | 2690 | 0.40 | Why? |
| Phylogeography | 5 | 2021 | 824 | 0.40 | Why? |
| Sequence Analysis, DNA | 2 | 2021 | 2830 | 0.39 | Why? |
| Likelihood Functions | 3 | 2020 | 719 | 0.32 | Why? |
| Models, Biological | 3 | 2021 | 4907 | 0.31 | Why? |
| Travel | 3 | 2021 | 7220 | 0.30 | Why? |
| Stochastic Processes | 2 | 2017 | 369 | 0.29 | Why? |
| Information Dissemination | 1 | 2021 | 2986 | 0.29 | Why? |
| Research Design | 2 | 2018 | 5830 | 0.29 | Why? |
| Influenza, Human | 6 | 2021 | 10779 | 0.24 | Why? |
| Computational Biology | 6 | 2021 | 4514 | 0.23 | Why? |
| Psychoses, Substance-Induced | 1 | 2021 | 91 | 0.21 | Why? |
| Antigens, Viral | 1 | 2017 | 6298 | 0.19 | Why? |
| Biological Evolution | 3 | 2020 | 641 | 0.19 | Why? |
| Computer Simulation | 6 | 2020 | 4982 | 0.19 | Why? |
| Observation | 1 | 2018 | 80 | 0.18 | Why? |
| Piracetam | 1 | 2017 | 6 | 0.18 | Why? |
| Molecular Epidemiology | 3 | 2021 | 1638 | 0.18 | Why? |
| Phenytoin | 1 | 2017 | 17 | 0.18 | Why? |
| Chemotherapy, Adjuvant | 1 | 2021 | 606 | 0.18 | Why? |
| Genome, Viral | 7 | 2021 | 13157 | 0.17 | Why? |
| History, 17th Century | 1 | 2017 | 172 | 0.16 | Why? |
| Host-Parasite Interactions | 1 | 2017 | 112 | 0.16 | Why? |
| Sample Size | 1 | 2018 | 518 | 0.16 | Why? |
| Factor Analysis, Statistical | 1 | 2018 | 538 | 0.15 | Why? |
| Biostatistics | 1 | 2017 | 116 | 0.15 | Why? |
| Mathematical Concepts | 1 | 2017 | 370 | 0.15 | Why? |
| Angioedema | 1 | 2017 | 111 | 0.15 | Why? |
| Confidence Intervals | 1 | 2018 | 744 | 0.15 | Why? |
| Logistic Models | 2 | 2020 | 9089 | 0.14 | Why? |
| Epidemiology | 1 | 2017 | 216 | 0.14 | Why? |
| Algorithms | 4 | 2021 | 7346 | 0.14 | Why? |
| Plague | 1 | 2017 | 155 | 0.14 | Why? |
| Reproducibility of Results | 2 | 2021 | 11304 | 0.13 | Why? |
| Statistics, Nonparametric | 1 | 2017 | 1008 | 0.13 | Why? |
| Probability | 1 | 2017 | 923 | 0.13 | Why? |
| Databases, Factual | 4 | 2021 | 6248 | 0.12 | Why? |
| Influenza A Virus, H3N2 Subtype | 1 | 2017 | 572 | 0.12 | Why? |
| Suicidal Ideation | 1 | 2021 | 1226 | 0.12 | Why? |
| Models, Statistical | 2 | 2021 | 5312 | 0.11 | Why? |
| Ebolavirus | 1 | 2018 | 834 | 0.11 | Why? |
| Swine Diseases | 1 | 2020 | 1219 | 0.10 | Why? |
| Cluster Analysis | 1 | 2017 | 3001 | 0.09 | Why? |
| Republic of Korea | 4 | 2021 | 5858 | 0.09 | Why? |
| United States | 11 | 2021 | 46150 | 0.09 | Why? |
| Suicide | 1 | 2021 | 1500 | 0.09 | Why? |
| Viruses | 2 | 2018 | 2238 | 0.09 | Why? |
| Autoimmune Diseases | 1 | 2021 | 1996 | 0.09 | Why? |
| Humans | 30 | 2021 | 930598 | 0.08 | Why? |
| Hemorrhagic Fever, Ebola | 1 | 2018 | 1475 | 0.08 | Why? |
| Communicable Diseases, Emerging | 1 | 2021 | 2523 | 0.08 | Why? |
| Forecasting | 1 | 2021 | 4492 | 0.08 | Why? |
| Antirheumatic Agents | 1 | 2021 | 3023 | 0.08 | Why? |
| Spain | 5 | 2021 | 15545 | 0.07 | Why? |
| Machine Learning | 2 | 2021 | 4395 | 0.07 | Why? |
| England | 1 | 2017 | 5116 | 0.07 | Why? |
| Epilepsy | 1 | 2017 | 1401 | 0.07 | Why? |
| Seasons | 1 | 2017 | 4071 | 0.07 | Why? |
| Coronavirus Infections | 6 | 2020 | 253789 | 0.06 | Why? |
| Animals | 5 | 2020 | 78931 | 0.06 | Why? |
| Cohort Studies | 6 | 2021 | 36005 | 0.06 | Why? |
| Hospitalization | 4 | 2021 | 54280 | 0.06 | Why? |
| Betacoronavirus | 4 | 2020 | 204454 | 0.06 | Why? |
| Drug Repositioning | 1 | 2021 | 5683 | 0.06 | Why? |
| Communicable Diseases | 1 | 2017 | 2148 | 0.06 | Why? |
| Influenza A Virus, H1N1 Subtype | 1 | 2017 | 2984 | 0.06 | Why? |
| Viral Proteins | 1 | 2020 | 7370 | 0.06 | Why? |
| Administrative Claims, Healthcare | 1 | 2021 | 124 | 0.06 | Why? |
| Germany | 3 | 2021 | 9196 | 0.06 | Why? |
| Hydroxychloroquine | 2 | 2021 | 12447 | 0.05 | Why? |
| Pneumonia, Viral | 5 | 2020 | 243684 | 0.05 | Why? |
| Case-Control Studies | 1 | 2019 | 17671 | 0.05 | Why? |
| Locomotion | 1 | 2021 | 130 | 0.05 | Why? |
| Spike Glycoprotein, Coronavirus | 2 | 2021 | 37182 | 0.05 | Why? |
| District of Columbia | 1 | 2021 | 343 | 0.05 | Why? |
| Fluoroquinolones | 1 | 2021 | 235 | 0.05 | Why? |
| Selection Bias | 1 | 2020 | 201 | 0.05 | Why? |
| Ceftriaxone | 1 | 2021 | 365 | 0.05 | Why? |
| Genomics | 2 | 2021 | 3118 | 0.05 | Why? |
| Prognosis | 2 | 2021 | 32490 | 0.05 | Why? |
| Databases, Nucleic Acid | 1 | 2021 | 272 | 0.04 | Why? |
| Africa, Western | 1 | 2018 | 363 | 0.04 | Why? |
| Epidemics | 1 | 2017 | 6407 | 0.04 | Why? |
| Depression | 1 | 2021 | 14116 | 0.04 | Why? |
| Selection, Genetic | 1 | 2020 | 691 | 0.04 | Why? |
| SARS Virus | 1 | 2020 | 13021 | 0.04 | Why? |
| Protein Structure, Secondary | 1 | 2020 | 1077 | 0.04 | Why? |
| Life Expectancy | 1 | 2021 | 474 | 0.04 | Why? |
| Washington | 1 | 2020 | 1722 | 0.04 | Why? |
| Data Interpretation, Statistical | 1 | 2019 | 657 | 0.04 | Why? |
| Prevalence | 3 | 2021 | 25773 | 0.03 | Why? |
| Genetic Variation | 2 | 2020 | 3919 | 0.03 | Why? |
| Community Networks | 1 | 2017 | 342 | 0.03 | Why? |
| Enoxaparin | 1 | 2021 | 1064 | 0.03 | Why? |
| Aged, 80 and over | 5 | 2021 | 88759 | 0.03 | Why? |
| California | 1 | 2020 | 2047 | 0.03 | Why? |
| Adolescent | 5 | 2021 | 86841 | 0.03 | Why? |
| Pandemics | 8 | 2021 | 389249 | 0.03 | Why? |
| Air Travel | 1 | 2020 | 585 | 0.03 | Why? |
| Recombination, Genetic | 1 | 2020 | 1265 | 0.03 | Why? |
| Open Reading Frames | 1 | 2020 | 1898 | 0.03 | Why? |
| Young Adult | 5 | 2021 | 93724 | 0.03 | Why? |
| Sex Factors | 2 | 2020 | 11014 | 0.03 | Why? |
| Safety | 1 | 2021 | 1583 | 0.03 | Why? |
| Male | 10 | 2021 | 367725 | 0.03 | Why? |
| Disease Outbreaks | 2 | 2018 | 27595 | 0.03 | Why? |
| Species Specificity | 1 | 2017 | 1356 | 0.03 | Why? |
| Time Factors | 3 | 2021 | 31397 | 0.03 | Why? |
| Neoplasms | 1 | 2021 | 17251 | 0.03 | Why? |
| Female | 10 | 2021 | 380317 | 0.03 | Why? |
| Interdisciplinary Communication | 1 | 2020 | 1425 | 0.03 | Why? |
| Comorbidity | 3 | 2021 | 34796 | 0.03 | Why? |
| Geography | 1 | 2018 | 1801 | 0.03 | Why? |
| Child | 4 | 2021 | 70012 | 0.03 | Why? |
| Swine | 1 | 2020 | 3352 | 0.03 | Why? |
| Age Distribution | 1 | 2021 | 3567 | 0.03 | Why? |
| Datasets as Topic | 1 | 2018 | 1404 | 0.03 | Why? |
| Drug Combinations | 1 | 2021 | 3852 | 0.03 | Why? |
| Coronavirus | 1 | 2020 | 18339 | 0.03 | Why? |
| Models, Theoretical | 2 | 2021 | 6659 | 0.03 | Why? |
| Weather | 1 | 2017 | 581 | 0.03 | Why? |
| Adult | 7 | 2021 | 244371 | 0.03 | Why? |
| Spatio-Temporal Analysis | 1 | 2017 | 1182 | 0.03 | Why? |
| Mutation | 2 | 2021 | 12376 | 0.03 | Why? |
| Aged | 6 | 2021 | 215776 | 0.03 | Why? |
| Infant, Newborn | 2 | 2021 | 23105 | 0.02 | Why? |
| China | 3 | 2021 | 50654 | 0.02 | Why? |
| Treatment Outcome | 3 | 2021 | 51732 | 0.02 | Why? |
| Age Factors | 2 | 2020 | 21039 | 0.02 | Why? |
| Health Surveys | 1 | 2020 | 2841 | 0.02 | Why? |
| Middle Aged | 6 | 2021 | 270681 | 0.02 | Why? |
| Infant | 2 | 2021 | 30274 | 0.02 | Why? |
| Epidemiological Monitoring | 1 | 2021 | 3493 | 0.02 | Why? |
| Electronic Health Records | 1 | 2021 | 3492 | 0.02 | Why? |
| Arthritis, Rheumatoid | 1 | 2021 | 2043 | 0.02 | Why? |
| Symptom Assessment | 1 | 2021 | 4967 | 0.02 | Why? |
| Incidence | 2 | 2021 | 25622 | 0.02 | Why? |
| Child, Preschool | 2 | 2021 | 36283 | 0.02 | Why? |
| Diagnosis, Differential | 1 | 2021 | 7220 | 0.02 | Why? |
| Lopinavir | 1 | 2021 | 4308 | 0.02 | Why? |
| Risk Factors | 3 | 2021 | 71621 | 0.02 | Why? |
| Models, Molecular | 1 | 2020 | 7616 | 0.02 | Why? |
| Ritonavir | 1 | 2021 | 4212 | 0.02 | Why? |
| Azithromycin | 1 | 2021 | 3943 | 0.02 | Why? |
| Risk Assessment | 2 | 2021 | 25439 | 0.02 | Why? |
| Vitamin D | 1 | 2021 | 2904 | 0.02 | Why? |
| Inpatients | 1 | 2021 | 5161 | 0.02 | Why? |
| Chiroptera | 1 | 2020 | 3530 | 0.02 | Why? |
| France | 1 | 2021 | 12074 | 0.02 | Why? |
| Europe | 1 | 2021 | 12702 | 0.02 | Why? |
| Protein Binding | 1 | 2021 | 11430 | 0.02 | Why? |
| Adrenal Cortex Hormones | 1 | 2021 | 6537 | 0.02 | Why? |
| Brazil | 1 | 2021 | 12582 | 0.02 | Why? |
| Health Services Needs and Demand | 1 | 2018 | 3419 | 0.02 | Why? |
| Receptors, Virus | 1 | 2020 | 5659 | 0.02 | Why? |
| Health Status Disparities | 1 | 2021 | 4072 | 0.02 | Why? |
| United Kingdom | 1 | 2021 | 18046 | 0.01 | Why? |
| Contact Tracing | 1 | 2020 | 8448 | 0.01 | Why? |
| Mass Screening | 1 | 2020 | 8005 | 0.01 | Why? |
| Viral Load | 1 | 2021 | 15850 | 0.01 | Why? |
| Population Surveillance | 1 | 2017 | 4967 | 0.01 | Why? |
| Virus Diseases | 1 | 2017 | 3779 | 0.01 | Why? |
| Host-Pathogen Interactions | 1 | 2017 | 11041 | 0.01 | Why? |
| Italy | 1 | 2020 | 38444 | 0.01 | Why? |
| Retrospective Studies | 1 | 2019 | 105322 | 0.01 | Why? |
Suchard's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(179)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(370)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_